Age-Related Macular Degeneration Revisited - Piecing the Puzzle: The LXIX Edward Jackson Memorial Lecture

Therapies based on pathophysiologic features have changed the paradigm for treating neovascular AMD. With improved understanding of the underlying genetic susceptibility, we can identify targets to halt early disease and to prevent progression and vision loss.